Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score.
Schaefer IM, Hornick JL, Barysauskas CM, Raut CP, Patel SA, Royce TJ, Fletcher CDM, Baldini EH.
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):375-383. doi: 10.1016/j.ijrobp.2017.02.087. Epub 2017 Feb 24.
Difficult Diagnosis between B Cell Lymphoma and Classical Hodgkin's Lymphoma.
Rentas Torres Y, Rodríguez-López JL, Valentin M, Silva H.
Bol Asoc Med P R. 2015 Jul-Sep;107(3):98-101.
Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual males.
Kalter SP, Riggs SA, Cabanillas F, Butler JJ, Hagemeister FB, Mansell PW, Newell GR, Velasquez WS, Salvador P, Barlogie B, et al.
Blood. 1985 Sep;66(3):655-9.
The surgical management of sarcomas of the chest wall: A 13-year single institution experience.
Crowley TP, Atkinson K, Bayliss CD, Barnard S, Milner RH, Ragbir M.
J Plast Reconstr Aesthet Surg. 2020 Aug;73(8):1448-1455. doi: 10.1016/j.bjps.2020.02.036. Epub 2020 Mar 4.
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.
Rodig SJ, Kutok JL, Paterson JC, Nitta H, Zhang W, Chapuy B, Tumwine LK, Montes-Moreno S, Agostinelli C, Johnson NA, Ben-Neriah S, Farinha P, Shipp MA, Piris MA, Grogan TM, Pileri SA, Gascoyne RD, Marafioti T.
Haematologica. 2010 Dec;95(12):2056-62. doi: 10.3324/haematol.2010.025767. Epub 2010 Sep 7.
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR.
Am J Surg Pathol. 2010 Mar;34(3):327-40. doi: 10.1097/PAS.0b013e3181cd3aeb.
Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy.
Li YX, Coucke PA, Li JY, Gu DZ, Liu XF, Zhou LQ, Mirimanoff RO, Yu ZH, Huang YR.
Cancer. 1998 Aug 1;83(3):449-56. doi: 10.1002/(sici)1097-0142(19980801)83:3<449::aid-cncr13>3.0.co;2-w.
Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors?
Kume H, Kakutani S, Yamada Y, Shinohara M, Tominaga T, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Nishimatsu H, Homma Y.
J Urol. 2011 May;185(5):1611-4. doi: 10.1016/j.juro.2010.12.037. Epub 2011 Mar 17.
Treatment outcome and prognostic factors for primary nasal lymphoma.
Liang R, Todd D, Chan TK, Chiu E, Lie A, Kwong YL, Choy D, Ho FC.
J Clin Oncol. 1995 Mar;13(3):666-70. doi: 10.1200/JCO.1995.13.3.666.
A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child.
Ahn JY, Seo YH, Park PW, Kim KH, Park MJ, Jeong JH, Park SH, Song YH.
Ann Lab Med. 2012 Mar;32(2):162-6. doi: 10.3343/alm.2012.32.2.162. Epub 2012 Feb 23.
